Intact cultured human lymphocytes will be treated with chromate and DNA- protein complexes will be isolated. Chromate crosslinked proteins will be released from the DNA by treatment with EDTA, which chelates the trivalent form of chromium and should cause the release of proteins and peptides that are complexed to the DNA. We will measure the quantity of released proteins and peptides as an indicator of DNA-protein crosslinking. Antibodies to specific proteins will assess the quantity of protein released by EDTA. These antibodies will include those directed to p97 protein, to actin, as well as to other proteins that we have identified as complexed to DNA. In conjunction with the in vitro study in human cells, a parallel approach will be employed using mice exposed to chromate by chronic i.p. injection or by drinking water exposure. The chronic i.p. injection or oral exposure will examine whether the procedures that are being utilized in vitro in cultured human lymphocytes (i.e., studying the proteins and amino acids/peptides released by EDTA) can be used to detect chromate exposure in animals using their peripheral blood lymphocytes as a sentinel of exposure. A similar approach will also be utilized to study DNA-protein crosslink formation in humans occupationally-exposed to chromium or humans exposed from chromate ground contamination in Hudson County, New Jersey. Traditional methods of assessing chromium exposure will be utilized to test the sensitivity of the DNA-protein complex detection method as a biomarker. These studies should yield a very sensitive method to measure DNA-protein crosslinks, lesion that are known to be formed by chromate as well as several other agents. At present there is not an adequate method to detect human chromate exposure and the studies proposed here should fill this void.

Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
New York University
New York
United States
Zip Code
Sutherland, J E; Zhitkovich, A; Kluz, T et al. (2000) Rats retain chromium in tissues following chronic ingestion of drinking water containing hexavalent chromium. Biol Trace Elem Res 74:41-53
Corti, M; Snyder, C A (1998) Gender- and age-specific cytotoxic susceptibility to benzene metabolites in vitro. Toxicol Sci 41:42-8
Salnikow, K; Wang, S; Costa, M (1997) Induction of activating transcription factor 1 by nickel and its role as a negative regulator of thrombospondin I gene expression. Cancer Res 57:5060-6
Klein, C B; Costa, M (1997) DNA methylation, heterochromatin and epigenetic carcinogens. Mutat Res 386:163-80
Gong, Z; Evans, H L (1997) Effect of chelation with meso-dimercaptosuccinic acid (DMSA) before and after the appearance of lead-induced neurotoxicity in the rat. Toxicol Appl Pharmacol 144:205-14
Zhitkovich, A; Voitkun, V; Costa, M (1996) Formation of the amino acid-DNA complexes by hexavalent and trivalent chromium in vitro: importance of trivalent chromium and the phosphate group. Biochemistry 35:7275-82
Lukanova, A; Toniolo, P; Zhitkovich, A et al. (1996) Occupational exposure to Cr(VI): comparison between chromium levels in lymphocytes, erythrocytes, and urine. Int Arch Occup Environ Health 69:39-44
Costa, M; Zhitkovich, A; Toniolo, P et al. (1996) Monitoring human lymphocytic DNA-protein cross-links as biomarkers of biologically active doses of chromate. Environ Health Perspect 104 Suppl 5:917-9
el-Fawal, H A; Gong, Z; Little, A R et al. (1996) Exposure to methylmercury results in serum autoantibodies to neurotypic and gliotypic proteins. Neurotoxicology 17:531-9
Dowjat, W K; Kharatishvili, M; Costa, M (1996) DNA and RNA strand scission by copper, zinc and manganese superoxide dismutases. Biometals 9:327-35

Showing the most recent 10 out of 106 publications